The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Furazolidone Market Research Report 2024

Global Furazolidone Market Research Report 2024

Publishing Date : Feb, 2021

License Type :
 

Report Code : 1581934

No of Pages : 95

Synopsis
Furazolidone is a nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone binds bacterial DNA which leads to the gradual inhibition of monoamine oxidase

The global Furazolidone market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Furazolidone volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Furazolidone market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Furazolidone Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Pharma Grade
Industrial Grade
Others

Segment by Application
Pharmacy
Industry

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Becton, Dickinson and Company (BD)
Daiichi Sankyo
GrÜNenthal Gmbh
Standpharm
Teva
Marvi
Ferring
Geo-Med
KPL Pharma
Keyfarm
Index
1 Furazolidone Market Overview
1.1 Product Overview and Scope of Furazolidone
1.2 Furazolidone Segment by Type
1.2.1 Global Furazolidone Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Pharma Grade
1.2.3 Industrial Grade
1.2.4 Others
1.3 Furazolidone Segment by Application
1.3.1 Furazolidone Sales Comparison by Application: (2021-2027)
1.3.2 Pharmacy
1.3.3 Industry
1.4 Global Furazolidone Market Size Estimates and Forecasts
1.4.1 Global Furazolidone Revenue 2016-2027
1.4.2 Global Furazolidone Sales 2016-2027
1.4.3 Furazolidone Market Size by Region: 2016 Versus 2021 Versus 2027

2 Furazolidone Market Competition by Manufacturers
2.1 Global Furazolidone Sales Market Share by Manufacturers (2016-2021)
2.2 Global Furazolidone Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Furazolidone Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Furazolidone Manufacturing Sites, Area Served, Product Type
2.5 Furazolidone Market Competitive Situation and Trends
2.5.1 Furazolidone Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Furazolidone Players Market Share by Revenue
2.5.3 Global Furazolidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Furazolidone Retrospective Market Scenario by Region
3.1 Global Furazolidone Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Furazolidone Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Furazolidone Market Facts & Figures by Country
3.3.1 North America Furazolidone Sales by Country
3.3.2 North America Furazolidone Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Furazolidone Market Facts & Figures by Country
3.4.1 Europe Furazolidone Sales by Country
3.4.2 Europe Furazolidone Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Furazolidone Market Facts & Figures by Region
3.5.1 Asia Pacific Furazolidone Sales by Region
3.5.2 Asia Pacific Furazolidone Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Furazolidone Market Facts & Figures by Country
3.6.1 Latin America Furazolidone Sales by Country
3.6.2 Latin America Furazolidone Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Furazolidone Market Facts & Figures by Country
3.7.1 Middle East and Africa Furazolidone Sales by Country
3.7.2 Middle East and Africa Furazolidone Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Furazolidone Historic Market Analysis by Type
4.1 Global Furazolidone Sales Market Share by Type (2016-2021)
4.2 Global Furazolidone Revenue Market Share by Type (2016-2021)
4.3 Global Furazolidone Price by Type (2016-2021)

5 Global Furazolidone Historic Market Analysis by Application
5.1 Global Furazolidone Sales Market Share by Application (2016-2021)
5.2 Global Furazolidone Revenue Market Share by Application (2016-2021)
5.3 Global Furazolidone Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Becton, Dickinson and Company (BD)
6.1.1 Becton, Dickinson and Company (BD) Corporation Information
6.1.2 Becton, Dickinson and Company (BD) Description and Business Overview
6.1.3 Becton, Dickinson and Company (BD) Furazolidone Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Becton, Dickinson and Company (BD) Product Portfolio
6.1.5 Becton, Dickinson and Company (BD) Recent Developments/Updates
6.2 Daiichi Sankyo
6.2.1 Daiichi Sankyo Corporation Information
6.2.2 Daiichi Sankyo Description and Business Overview
6.2.3 Daiichi Sankyo Furazolidone Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Daiichi Sankyo Product Portfolio
6.2.5 Daiichi Sankyo Recent Developments/Updates
6.3 GrÜNenthal Gmbh
6.3.1 GrÜNenthal Gmbh Corporation Information
6.3.2 GrÜNenthal Gmbh Description and Business Overview
6.3.3 GrÜNenthal Gmbh Furazolidone Sales, Revenue and Gross Margin (2016-2021)
6.3.4 GrÜNenthal Gmbh Product Portfolio
6.3.5 GrÜNenthal Gmbh Recent Developments/Updates
6.4 Standpharm
6.4.1 Standpharm Corporation Information
6.4.2 Standpharm Description and Business Overview
6.4.3 Standpharm Furazolidone Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Standpharm Product Portfolio
6.4.5 Standpharm Recent Developments/Updates
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Furazolidone Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Teva Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Marvi
6.6.1 Marvi Corporation Information
6.6.2 Marvi Description and Business Overview
6.6.3 Marvi Furazolidone Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Marvi Product Portfolio
6.6.5 Marvi Recent Developments/Updates
6.7 Ferring
6.6.1 Ferring Corporation Information
6.6.2 Ferring Description and Business Overview
6.6.3 Ferring Furazolidone Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ferring Product Portfolio
6.7.5 Ferring Recent Developments/Updates
6.8 Geo-Med
6.8.1 Geo-Med Corporation Information
6.8.2 Geo-Med Description and Business Overview
6.8.3 Geo-Med Furazolidone Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Geo-Med Product Portfolio
6.8.5 Geo-Med Recent Developments/Updates
6.9 KPL Pharma
6.9.1 KPL Pharma Corporation Information
6.9.2 KPL Pharma Description and Business Overview
6.9.3 KPL Pharma Furazolidone Sales, Revenue and Gross Margin (2016-2021)
6.9.4 KPL Pharma Product Portfolio
6.9.5 KPL Pharma Recent Developments/Updates
6.10 Keyfarm
6.10.1 Keyfarm Corporation Information
6.10.2 Keyfarm Description and Business Overview
6.10.3 Keyfarm Furazolidone Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Keyfarm Product Portfolio
6.10.5 Keyfarm Recent Developments/Updates

7 Furazolidone Manufacturing Cost Analysis
7.1 Furazolidone Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Furazolidone
7.4 Furazolidone Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Furazolidone Distributors List
8.3 Furazolidone Customers

9 Furazolidone Market Dynamics
9.1 Furazolidone Industry Trends
9.2 Furazolidone Growth Drivers
9.3 Furazolidone Market Challenges
9.4 Furazolidone Market Restraints

10 Global Market Forecast
10.1 Furazolidone Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Furazolidone by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Furazolidone by Type (2022-2027)
10.2 Furazolidone Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Furazolidone by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Furazolidone by Application (2022-2027)
10.3 Furazolidone Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Furazolidone by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Furazolidone by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Furazolidone Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Furazolidone Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Furazolidone Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Furazolidone Covered in This Study
Table 5. Global Furazolidone Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Furazolidone Sales Share by Manufacturers (2016-2021)
Table 7. Global Furazolidone Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Furazolidone Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Furazolidone Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Furazolidone Manufacturing Sites and Area Served
Table 11. Manufacturers Furazolidone Product Type
Table 12. Global Furazolidone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Furazolidone by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Furazolidone as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Furazolidone Sales by Region (2016-2021) & (K Units)
Table 16. Global Furazolidone Sales Market Share by Region (2016-2021)
Table 17. Global Furazolidone Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Furazolidone Sales by Country (2016-2021) & (K Units)
Table 19. North America Furazolidone Sales Market Share by Country (2016-2021)
Table 20. North America Furazolidone Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Furazolidone Revenue Market Share by Country (2016-2021)
Table 22. Europe Furazolidone Sales by Country (2016-2021) & (K Units)
Table 23. Europe Furazolidone Sales Market Share by Country (2016-2021)
Table 24. Europe Furazolidone Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Furazolidone Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Furazolidone Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Furazolidone Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Furazolidone Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Furazolidone Revenue Market Share by Region (2016-2021)
Table 30. Latin America Furazolidone Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Furazolidone Sales Market Share by Country (2016-2021)
Table 32. Latin America Furazolidone Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Furazolidone Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Furazolidone Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Furazolidone Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Furazolidone Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Furazolidone Revenue Market Share by Country (2016-2021)
Table 38. Global Furazolidone Sales (K Units) by Type (2016-2021)
Table 39. Global Furazolidone Sales Market Share by Type (2016-2021)
Table 40. Global Furazolidone Revenue (Million US$) by Type (2016-2021)
Table 41. Global Furazolidone Revenue Share by Type (2016-2021)
Table 42. Global Furazolidone Price (US$/Unit) by Type (2016-2021)
Table 43. Global Furazolidone Sales (K Units) by Application (2016-2021)
Table 44. Global Furazolidone Sales Market Share by Application (2016-2021)
Table 45. Global Furazolidone Revenue (Million US$) by Application (2016-2021)
Table 46. Global Furazolidone Revenue Share by Application (2016-2021)
Table 47. Global Furazolidone Price (US$/Unit) by Application (2016-2021)
Table 48. Becton, Dickinson and Company (BD) Corporation Information
Table 49. Becton, Dickinson and Company (BD) Description and Business Overview
Table 50. Becton, Dickinson and Company (BD) Furazolidone Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Becton, Dickinson and Company (BD) Furazolidone Product
Table 52. Becton, Dickinson and Company (BD) Recent Developments/Updates
Table 53. Daiichi Sankyo Corporation Information
Table 54. Daiichi Sankyo Description and Business Overview
Table 55. Daiichi Sankyo Furazolidone Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Daiichi Sankyo Furazolidone Product
Table 57. Daiichi Sankyo Recent Developments/Updates
Table 58. GrÜNenthal Gmbh Corporation Information
Table 59. GrÜNenthal Gmbh Description and Business Overview
Table 60. GrÜNenthal Gmbh Furazolidone Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. GrÜNenthal Gmbh Furazolidone Product
Table 62. GrÜNenthal Gmbh Recent Developments/Updates
Table 63. Standpharm Corporation Information
Table 64. Standpharm Description and Business Overview
Table 65. Standpharm Furazolidone Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Standpharm Furazolidone Product
Table 67. Standpharm Recent Developments/Updates
Table 68. Teva Corporation Information
Table 69. Teva Description and Business Overview
Table 70. Teva Furazolidone Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Teva Furazolidone Product
Table 72. Teva Recent Developments/Updates
Table 73. Marvi Corporation Information
Table 74. Marvi Description and Business Overview
Table 75. Marvi Furazolidone Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Marvi Furazolidone Product
Table 77. Marvi Recent Developments/Updates
Table 78. Ferring Corporation Information
Table 79. Ferring Description and Business Overview
Table 80. Ferring Furazolidone Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Ferring Furazolidone Product
Table 82. Ferring Recent Developments/Updates
Table 83. Geo-Med Corporation Information
Table 84. Geo-Med Description and Business Overview
Table 85. Geo-Med Furazolidone Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Geo-Med Furazolidone Product
Table 87. Geo-Med Recent Developments/Updates
Table 88. KPL Pharma Corporation Information
Table 89. KPL Pharma Description and Business Overview
Table 90. KPL Pharma Furazolidone Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. KPL Pharma Furazolidone Product
Table 92. KPL Pharma Recent Developments/Updates
Table 93. Keyfarm Corporation Information
Table 94. Keyfarm Description and Business Overview
Table 95. Keyfarm Furazolidone Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Keyfarm Furazolidone Product
Table 97. Keyfarm Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Furazolidone Distributors List
Table 101. Furazolidone Customers List
Table 102. Furazolidone Market Trends
Table 103. Furazolidone Growth Drivers
Table 104. Furazolidone Market Restraints
Table 105. Global Furazolidone Sales Forecast by Type (2022-2027) & (K Units)
Table 106. Global Furazolidone Sales Market Share Forecast by Type (2022-2027)
Table 107. Global Furazolidone Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 108. Global Furazolidone Revenue Market Share Forecast by Type (2022-2027)
Table 109. Global Furazolidone Sales Forecast by Application (2022-2027) & (K Units)
Table 110. Global Furazolidone Sales Market Share Forecast by Application (2022-2027)
Table 111. Global Furazolidone Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 112. Global Furazolidone Revenue Market Share Forecast by Application (2022-2027)
Table 113. Global Furazolidone Sales Forecast by Region (2022-2027) & (K Units)
Table 114. Global Furazolidone Sales Market Share Forecast by Region (2022-2027)
Table 115. Global Furazolidone Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 116. Global Furazolidone Revenue Market Share Forecast by Region (2022-2027)
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Furazolidone
Figure 2. Global Furazolidone Market Share by Type in 2020 & 2027
Figure 3. Pharma Grade Product Picture
Figure 4. Industrial Grade Product Picture
Figure 5. Others Product Picture
Figure 6. Global Furazolidone Market Share by Application in 2020 & 2027
Figure 7. Pharmacy
Figure 8. Industry
Figure 9. Global Furazolidone Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Furazolidone Market Size 2016-2027 (US$ Million)
Figure 11. Global Furazolidone Sales 2016-2027 (K Units)
Figure 12. Global Furazolidone Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Furazolidone Sales Share by Manufacturers in 2020
Figure 14. Global Furazolidone Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Furazolidone Players: Market Share by Revenue in 2020
Figure 16. Furazolidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Furazolidone Sales Market Share by Region (2016-2021)
Figure 18. Global Furazolidone Sales Market Share by Region in 2020
Figure 19. Global Furazolidone Revenue Market Share by Region (2016-2021)
Figure 20. Global Furazolidone Revenue Market Share by Region in 2020
Figure 21. U.S. Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Furazolidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Furazolidone by Type (2016-2021)
Figure 46. Sales Market Share of Furazolidone by Application (2016-2021)
Figure 47. Sales Market Share of Furazolidone by Application in 2020
Figure 48. Revenue Share of Furazolidone by Application (2016-2021)
Figure 49. Revenue Share of Furazolidone by Application in 2020
Figure 50. Manufacturing Cost Structure of Furazolidone
Figure 51. Manufacturing Process Analysis of Furazolidone
Figure 52. Furazolidone Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’